Hacker News new | past | comments | ask | show | jobs | submit login
French study finds anti-malarial/antibiotic combo could reduce Covid-19 duration (techcrunch.com)
1 point by coldcode on March 20, 2020 | hide | past | favorite | 2 comments



The control group is not randomized, and most of it is in another(s) hospital(s).

They are not counting the 6 patients that they lost in the treatment group (2 leave, 3 where transfer to ICU, 1 die). It is more strange that they didn't lost any patient in the control group.

It's strange that they use an antibiotic against a viral infection.

More discussion in https://news.ycombinator.com/item?id=22624955


There definitely needs to be more randomized trials regarding hydroxychloroquine. It can have adverse side-effects on the eyes and/or kidneys. It is not a benign compound.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: